Cough Suppressant Pholcodine Set For EU-Wide Ban
Executive Summary
Safety concerns have led a European Medicines Agency committee to recommend the withdrawal of marketing authorizations for all pholcodine-containing drugs sold in the EU, including both OTC and Rx presentations.
You may also be interested in...
National Regulators Back European Pholcodine Ban
By majority vote, the Heads of Medicines Agencies' CMDh has agreed to withdraw the marketing authorizations for all drugs containing pholcodine sold in the EU and European Economic Area countries.
EMA Starts Safety Review Of Cough Drugs Containing Pholcodine
The European Medicines Agency is reviewing the safety of cough suppressants containing the opioid pholcodine after a French study found new evidence linking these products to an increased risk of anaphylactic reactions to drugs used in general anesthesia.
Marinomed Takes Virus-Blocking Device Into Allergy And Dry Eye Categories
Virus-blocking compound Carragelose, out-licensed to major consumer health players such as Perrigo and Reckitt for use in OTC respiratory nasal sprays, is being adapted for use in the dry eye and allergy categories.